# Altman Rules Out an OpenAI Listing in 2026 and Blames Safety, Not Markets

Investor Michael Burry says the reverse is true, arguing that the labs' safety warnings are promotional material ahead of eventual offerings.

- Published: 2026-09-16T06:18:31.385Z
- Canonical: https://polylog.news/ai/2026-09-16/altman-rules-out-an-openai-listing-in-2026-and-blames-safety
- Publisher: Polylog (AI desk)
- Section: markets
- Sources: [Polylog editors](https://polylog.news)

OpenAI chief executive Sam Altman told Fortune that an OpenAI initial public offering will not happen this year, saying that "given everything happening with safety, right now would be an ill-advised moment to go public," and that the company feels no pressure to list. Fortune's follow-up on 15 September reported that the [window has moved to 2027 and that market conditions are not the reason](https://fortune.com/2026/09/15/sam-altman-says-openai-ipo-window-pushed-2027-but-markets-arent-the-culprit/). Russian-language coverage of the interview [emphasized Altman's argument](https://t.me/ai_machinelearning_big_data/10934) that quarterly public-market pressure is incompatible with the control work that building highly capable systems requires.

Investor Michael Burry put the opposite construction on the same facts, arguing in comments [circulated by AI Post](https://t.me/aipost/8154) that OpenAI and Anthropic are manufacturing safety alarm because growth is slowing, that competitors are narrowing the gap with the incumbents, and that an eventual offering needs a supporting narrative. Burry also disputed the premise itself, saying large language models are not on a path to general intelligence, so there is nothing to slow down.

Neither claim is checkable from outside. OpenAI does not publish audited revenue or margin, so "slow growth" is an inference, and "safety" is a stated motive that also happens to postpone the disclosure a listing would force. What is verifiable is the structural consequence: the largest private AI companies keep funding themselves through private rounds and compute arrangements with vendors, which means public investors reach the frontier only through Microsoft, NVIDIA, Oracle and other listed suppliers, and price AI exposure off those balance sheets rather than the labs' own.

## What this means

Every year the leading labs stay private, the listed proxies absorb more of the AI trade, so each additional dollar of investor enthusiasm flows into semiconductor and cloud earnings rather than into model revenue that no one can audit. That concentration has consequences in both directions. The suppliers capture the investment flows, but they would also absorb a decline first if lab spending slows, because there is no separately traded OpenAI stock to absorb it instead. The decisive question is whether OpenAI's 2027 window arrives with audited financials that validate the current private marks, or whether another private round sets the valuation again and the public market keeps pricing frontier AI exposure indirectly.

## What to watch

- Any OpenAI disclosure of audited revenue or gross margin ahead of a listing, which would let outside investors test both Altman's and Burry's competing accounts of growth.
- The size and pricing of the next large private round at OpenAI or Anthropic, since private marks are currently the only valuation signal and they set the reference for the whole sector.
- Whether other late-stage AI companies follow the delay, because a broader shift away from listing keeps AI returns inside private vehicles and out of index exposure.